Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
30.84
-0.05 (-0.16%)
At close: Jul 15, 2026, 4:00 PM EDT
31.00
+0.16 (0.52%)
After-hours: Jul 15, 2026, 7:22 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $3.07 billion as of July 15, 2026. Its market cap has increased by 85.12% in one year.
Market Cap
3.07B
Enterprise Value
2.15B
1-Year Change
85.12%
Ranking
Category
Stock Price
$30.84
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $3.07B, an increase of 835.96%. That is a compound annual growth rate of 41.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 3.07B | 12.21% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 3.55B |
| IDEAYA Biosciences | 3.47B |
| Alumis | 3.47B |
| Arcutis Biotherapeutics | 3.36B |
| Ultragenyx Pharmaceutical | 3.15B |
| Vera Therapeutics | 3.09B |
| Celldex Therapeutics | 3.03B |
| uniQure | 2.90B |